Literature DB >> 28641043

Radiogenomics of High-Grade Serous Ovarian Cancer: Multireader Multi-Institutional Study from the Cancer Genome Atlas Ovarian Cancer Imaging Research Group.

Hebert Alberto Vargas1, Erich P Huang1, Yulia Lakhman1, Joseph E Ippolito1, Priya Bhosale1, Vincent Mellnick1, Atul B Shinagare1, Maria Anello1, Justin Kirby1, Brenda Fevrier-Sullivan1, John Freymann1, C Carl Jaffe1, Evis Sala1.   

Abstract

Purpose To evaluate interradiologist agreement on assessments of computed tomography (CT) imaging features of high-grade serous ovarian cancer (HGSOC), to assess their associations with time-to-disease progression (TTP) and HGSOC transcriptomic profiles (Classification of Ovarian Cancer [CLOVAR]), and to develop an imaging-based risk score system to predict TTP and CLOVAR profiles. Materials and Methods This study was a multireader, multi-institutional, institutional review board-approved, HIPAA-compliant retrospective analysis of 92 patients with HGSOC (median age, 61 years) with abdominopelvic CT before primary cytoreductive surgery available through the Cancer Imaging Archive. Eight radiologists from the Cancer Genome Atlas Ovarian Cancer Imaging Research Group developed and independently recorded the following CT features: characteristics of primary ovarian mass(es), presence of definable mesenteric implants and infiltration, presence of other implants, presence and distribution of peritoneal spread, presence and size of pleural effusions and ascites, lymphadenopathy, and distant metastases. Interobserver agreement for CT features was assessed, as were univariate and multivariate associations with TTP and CLOVAR mesenchymal profile (worst prognosis). Results Interobserver agreement for some features was strong (eg, α = .78 for pleural effusion and ascites) but was lower for others (eg, α = .08 for intraparenchymal splenic metastases). Presence of peritoneal disease in the right upper quadrant (P = .0003), supradiaphragmatic lymphadenopathy (P = .0004), more peritoneal disease sites (P = .0006), and nonvisualization of a discrete ovarian mass (P = .0037) were associated with shorter TTP. More peritoneal disease sites (P = .0025) and presence of pouch of Douglas implants (P = .0045) were associated with CLOVAR mesenchymal profile. Combinations of imaging features contained predictive signal for TTP (concordance index = 0.658; P = .0006) and CLOVAR profile (mean squared deviation = 1.776; P = .0043). Conclusion These results provide some evidence of the clinical and biologic validity of these image features. Interobserver agreement is strong for some features, but could be improved for others. © RSNA, 2017 Online supplemental material is available for this article.

Entities:  

Mesh:

Year:  2017        PMID: 28641043      PMCID: PMC5673051          DOI: 10.1148/radiol.2017161870

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  17 in total

Review 1.  Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors.

Authors:  F E Harrell; K L Lee; D B Mark
Journal:  Stat Med       Date:  1996-02-28       Impact factor: 2.373

2.  Radiogenomics of clear cell renal cell carcinoma: preliminary findings of The Cancer Genome Atlas-Renal Cell Carcinoma (TCGA-RCC) Imaging Research Group.

Authors:  Atul B Shinagare; Raghu Vikram; Carl Jaffe; Oguz Akin; Justin Kirby; Erich Huang; John Freymann; Nisha I Sainani; Cheryl A Sadow; Tharakeswara K Bathala; Daniel L Rubin; Aytekin Oto; Matthew T Heller; Venkateswar R Surabhi; Venkat Katabathina; Stuart G Silverman
Journal:  Abdom Imaging       Date:  2015-08

3.  Association between morphologic CT imaging traits and prognostically relevant gene signatures in women with high-grade serous ovarian cancer: a hypothesis-generating study.

Authors:  Hebert Alberto Vargas; Maura Miccò; Seong Im Hong; Debra A Goldman; Fanny Dao; Britta Weigelt; Robert A Soslow; Hedvig Hricak; Douglas A Levine; Evis Sala
Journal:  Radiology       Date:  2014-11-10       Impact factor: 11.105

4.  LRP1B deletion in high-grade serous ovarian cancers is associated with acquired chemotherapy resistance to liposomal doxorubicin.

Authors:  Prue A Cowin; Joshy George; Sian Fereday; Elizabeth Loehrer; Peter Van Loo; Carleen Cullinane; Dariush Etemadmoghadam; Sarah Ftouni; Laura Galletta; Michael S Anglesio; Joy Hendley; Leanne Bowes; Karen E Sheppard; Elizabeth L Christie; Richard B Pearson; Paul R Harnett; Viola Heinzelmann-Schwarz; Michael Friedlander; Orla McNally; Michael Quinn; Peter Campbell; Anna deFazio; David D L Bowtell
Journal:  Cancer Res       Date:  2012-08-15       Impact factor: 12.701

5.  Prognostically relevant gene signatures of high-grade serous ovarian carcinoma.

Authors:  Roel G W Verhaak; Pablo Tamayo; Ji-Yeon Yang; Diana Hubbard; Hailei Zhang; Chad J Creighton; Sian Fereday; Michael Lawrence; Scott L Carter; Craig H Mermel; Aleksandar D Kostic; Dariush Etemadmoghadam; Gordon Saksena; Kristian Cibulskis; Sekhar Duraisamy; Keren Levanon; Carrie Sougnez; Aviad Tsherniak; Sebastian Gomez; Robert Onofrio; Stacey Gabriel; Lynda Chin; Nianxiang Zhang; Paul T Spellman; Yiqun Zhang; Rehan Akbani; Katherine A Hoadley; Ari Kahn; Martin Köbel; David Huntsman; Robert A Soslow; Anna Defazio; Michael J Birrer; Joe W Gray; John N Weinstein; David D Bowtell; Ronny Drapkin; Jill P Mesirov; Gad Getz; Douglas A Levine; Matthew Meyerson
Journal:  J Clin Invest       Date:  2012-12-21       Impact factor: 14.808

6.  MR imaging predictors of molecular profile and survival: multi-institutional study of the TCGA glioblastoma data set.

Authors:  David A Gutman; Lee A D Cooper; Scott N Hwang; Chad A Holder; Jingjing Gao; Tarun D Aurora; William D Dunn; Lisa Scarpace; Tom Mikkelsen; Rajan Jain; Max Wintermark; Manal Jilwan; Prashant Raghavan; Erich Huang; Robert J Clifford; Pattanasak Mongkolwat; Vladimir Kleper; John Freymann; Justin Kirby; Pascal O Zinn; Carlos S Moreno; Carl Jaffe; Rivka Colen; Daniel L Rubin; Joel Saltz; Adam Flanders; Daniel J Brat
Journal:  Radiology       Date:  2013-02-07       Impact factor: 11.105

7.  Cancer statistics, 1995.

Authors:  P A Wingo; T Tong; S Bolden
Journal:  CA Cancer J Clin       Date:  1995 Jan-Feb       Impact factor: 508.702

8.  Integrated genomic analyses of ovarian carcinoma.

Authors: 
Journal:  Nature       Date:  2011-06-29       Impact factor: 49.962

9.  Copy number variation analysis of matched ovarian primary tumors and peritoneal metastasis.

Authors:  Joel A Malek; Eliane Mery; Yasmin A Mahmoud; Eman K Al-Azwani; Laurence Roger; Ruby Huang; Eva Jouve; Raphael Lis; Jean-Paul Thiery; Denis Querleu; Arash Rafii
Journal:  PLoS One       Date:  2011-12-14       Impact factor: 3.240

10.  Bias in error estimation when using cross-validation for model selection.

Authors:  Sudhir Varma; Richard Simon
Journal:  BMC Bioinformatics       Date:  2006-02-23       Impact factor: 3.169

View more
  21 in total

1.  Radiomics of high-grade serous ovarian cancer: association between quantitative CT features, residual tumour and disease progression within 12 months.

Authors:  Stefania Rizzo; Francesca Botta; Sara Raimondi; Daniela Origgi; Valentina Buscarino; Anna Colarieti; Federica Tomao; Giovanni Aletti; Vanna Zanagnolo; Maria Del Grande; Nicoletta Colombo; Massimo Bellomi
Journal:  Eur Radiol       Date:  2018-05-08       Impact factor: 5.315

2.  Radiogenomics of rectal adenocarcinoma in the era of precision medicine: A pilot study of associations between qualitative and quantitative MRI imaging features and genetic mutations.

Authors:  Natally Horvat; Harini Veeraraghavan; Raphael A Pelossof; Maria Clara Fernandes; Arshi Arora; Monika Khan; Michael Marco; Chin-Tung Cheng; Mithat Gonen; Jennifer S Golia Pernicka; Marc J Gollub; Julio Garcia-Aguillar; Iva Petkovska
Journal:  Eur J Radiol       Date:  2019-02-18       Impact factor: 3.528

Review 3.  Background, current role, and potential applications of radiogenomics.

Authors:  Katja Pinker; Fuki Shitano; Evis Sala; Richard K Do; Robert J Young; Andreas G Wibmer; Hedvig Hricak; Elizabeth J Sutton; Elizabeth A Morris
Journal:  J Magn Reson Imaging       Date:  2017-11-02       Impact factor: 4.813

Review 4.  CT of Ovarian Cancer for Primary Treatment Planning: What the Surgeon Needs to Know-Radiology In Training.

Authors:  Maria Clara Fernandes; Ines Nikolovski; Kara Long Roche; Yulia Lakhman
Journal:  Radiology       Date:  2022-05-24       Impact factor: 29.146

Review 5.  Role of Artificial Intelligence in Radiogenomics for Cancers in the Era of Precision Medicine.

Authors:  Sanjay Saxena; Biswajit Jena; Neha Gupta; Suchismita Das; Deepaneeta Sarmah; Pallab Bhattacharya; Tanmay Nath; Sudip Paul; Mostafa M Fouda; Manudeep Kalra; Luca Saba; Gyan Pareek; Jasjit S Suri
Journal:  Cancers (Basel)       Date:  2022-06-09       Impact factor: 6.575

6.  Ovarian cancer reporting lexicon for computed tomography (CT) and magnetic resonance (MR) imaging developed by the SAR Uterine and Ovarian Cancer Disease-Focused Panel and the ESUR Female Pelvic Imaging Working Group.

Authors:  Elizabeth A Sadowski; Atul B Shinagare; Hyesun Park; Olga R Brook; Rosemarie Forstner; Sumer K Wallace; Jeanne M Horowitz; Neil Horowitz; Marcia Javitt; Priyanka Jha; Aki Kido; Yulia Lakhman; Susanna I Lee; Lucia Manganaro; Katherine E Maturen; Stephanie Nougaret; Liina Poder; Gaiane M Rauch; Caroline Reinhold; Evis Sala; Isabelle Thomassin-Naggara; Herbert Alberto Vargas; Aradhana Venkatesan; Olivera Nikolic; Andrea G Rockall
Journal:  Eur Radiol       Date:  2021-11-30       Impact factor: 7.034

Review 7.  Current update on malignant epithelial ovarian tumors.

Authors:  Sherif B Elsherif; Priya R Bhosale; Chandana Lall; Christine O Menias; Malak Itani; Kristina A Butler; Dhakshinamoorthy Ganeshan
Journal:  Abdom Radiol (NY)       Date:  2021-06-05

Review 8.  The Biological Meaning of Radiomic Features.

Authors:  Michal R Tomaszewski; Robert J Gillies
Journal:  Radiology       Date:  2021-01-05       Impact factor: 11.105

Review 9.  Ovarian cancer staging: What the surgeon needs to know.

Authors:  Lucas Roberto Lelis Botelho de Oliveira; Natally Horvat; Pamela Ines Causa Andrieu; Pedro Sergio Brito Panizza; Giovanni Guido Cerri; Publio Cesar Cavalcante Viana
Journal:  Br J Radiol       Date:  2021-07-21       Impact factor: 3.629

Review 10.  Radiomics and radiogenomics in ovarian cancer: a literature review.

Authors:  S Nougaret; Cathal McCague; Hichem Tibermacine; Hebert Alberto Vargas; Stefania Rizzo; E Sala
Journal:  Abdom Radiol (NY)       Date:  2020-11-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.